Mekinist

Product Description

What is Mekinist ?

MEKINIST® is a medicine used to treat a type of skin cancer called melanoma that has spread to other parts of the body or cannot be removed by surgery.

MEKINIST® should only be used for people whose cancer has a particular change (mutation) in a gene called “BRAF”. You should have your cancer tested for this change in the BRAF gene before starting treatment with MEKINIST®

How supplied/storage and handling ?

MEKINIST (trametinib) tablets are supplied as 0.5-mg, 1-mg, and 2-mg tablets for oral administration.

0.5-mg Tablets: Yellow, modified oval, biconvex, film-coated tablets with ‘GS’ debossed on one face and ‘TFC’ on the opposing face and are available in bottles of 30 (NDC 0173-0849-13).

1-mg Tablets: White, round, biconvex, film-coated tablets with ‘GS’ debossed on one face and ‘LHE’ on the opposing face and are available in bottles of 30 (NDC 0173-0858-13).

2-mg Tablets: Pink, round, biconvex, film-coated tablets with ‘GS’ debossed on one face and ‘HMJ’ on the opposing face and are available in bottles of 30 (NDC 0173-0848-13).

Store refrigerated at 2° to 8°C (36° to 46°F). Do not freeze. Dispense in original bottle. Do not remove desiccant. Protect from moisture and light. Do not place medication in pill boxes.